Proactive investors ‘ReNeuron Group agrees £80mln cell therapy licensing deal for China’
H.C. Wainwright & Co. global life sciences conference
ReNeuron will be presenting at the H.C. Wainwright & Co. global life sciences conference in London on April 9th, 2019.
Details of the conference can be found on our Events page.
The ReNeuron presentation can be accessed by webcast on April 9, 2019 3:30 p.m. (BST)
Click here to register for the webcast…
ARM Cell & Gene Therapy Investor Day, NY webcast 21 March 2019
Alliance for Regenerative Medicine : Cell & Gene investor day
Olav Hellebo, ReNeuron CEO will be presenting via webcast at the Alliance for Regenerative Medicine : Cell & Gene investor day on March 21, 2019.
ReNeuron’s slot is approximately 9.10am Eastern time (approx. 1.10 pm UK time)
To listen, please follow the link to access further information
Click to access webcast…
Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’
Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’
Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma”
OIS: Ophthalmology Innovation & Investment – ReNeuron using hRPCs to treat inherited retinal degenerative diseases
Interim Results for the six months ended 30 September 2018
14 December 2018: To log on to view a recording of the webcast of the analyst presentation, please click here.
To view the Interim Results Presentation slides please click here.
CFO presents at the 8th Annual Partnering Forum on the Mesa 2018